pmid	doi	year	title	Hugo_Symbol
29263590	10.14202/vetworld.2017.1307-1313	2022	Immunocytochemical study of canine lymphomas and its correlation with exposure to tobacco smoke.	PAX5
29296913	10.1182/bloodadvances.2017009472	2022	Clinicopathologic consensus study of gray zone lymphoma with features intermediate between DLBCL and classical HL.	PAX5
33398683	10.1007/s12105-020-01276-3	2022	Combined Modality Management of Sinonasal Anaplastic Lymphoma Kinase Negative Anaplastic Large Cell Lymphoma in a Geriatric Patient-Report of a Rare Case.	PAX5
34049715	10.1016/j.pathol.2021.02.013	2022	Expression of BCL6 in paediatric B-cell acute lymphoblastic leukaemia and association with prognosis.	PAX5
34190415	10.1002/dc.24821	2022	ALK-negative anaplastic large cell lymphoma, null type with aberrant expression of PAX5 and CD138: A diagnostic pitfall.	PAX5
34282671	10.1177/03009858211030523	2022	Histopathological features and immunophenotyping of canine transmural gastrointestinal lymphoma using full-thickness biopsy samples.	PAX5
34310368	10.1097/PAS.0000000000001785	2022	Reactive Intralymphovascular Immunoblastic Proliferations Mimicking Aggressive Lymphomas.	PAX5
34371436	10.1016/j.leukres.2021.106683	2022	Proposal and clinical application of molecular genetic risk scoring system, MRplus, for BCR-ABL1 negative pediatric B-cell acute lymphoblastic leukemia- report from a single centre.	PAX5
34374890	10.1007/s12029-021-00662-6	2022	Primary ALK-Positive Large B Cell Lymphoma of Pancreas.	PAX5
34499743	10.1111/1556-4029.14879	2022	Sudden death in an adolescent due to undiagnosed classic Hodgkin lymphoma.	PAX5
34547766	10.1182/bloodadvances.2021004895	2022	Distinct clinical characteristics of DUX4- and PAX5-altered childhood B-lymphoblastic leukemia.	PAX5
34560683	10.1097/PAS.0000000000001813	2022	A Comprehensive Clinicopathologic and Molecular Study of 19 Primary Effusion Lymphomas in HIV-infected Patients.	PAX5
34591292	10.1007/s12185-021-03229-0	2022	Successful treatment of hepatosplenic T-cell lymphoma with fludarabine, high-dose cytarabine and subsequent unrelated umbilical cord blood transplantation.	PAX5
34657128	10.1038/s41375-021-01448-2	2022	Prognostic impact of chromosomal abnormalities and copy number alterations in adult B-cell precursor acute lymphoblastic leukaemia: a UKALL14 study.	PAX5
34707037	10.3960/jslrt.21025	2022	t(9;14)(p13;q32)/PAX5-IGH translocation as a secondary cytogenetic abnormality in diffuse large B-cell lymphoma.	PAX5
34747234	10.1177/00031348211054526	2022	Primary Parotid Non-Hodgkin's B-Cell Lymphoma in an Elderly Woman on Pembrolizumab for Metastatic Invasive Papillary Urothelial Cell Carcinoma of the Bladder.	PAX5
34753926	10.1038/s41408-021-00570-9	2022	Cancer drivers and clonal dynamics in acute lymphoblastic leukaemia subtypes.	PAX5
34787376	10.1002/cnr2.1587	2022	Philadelphia-like acute lymphoblastic leukemia: Characterization in a pediatric cohort in a referral center in Colombia.	PAX5
34801601	10.1016/j.humpath.2021.11.007	2022	Clinicopathological features of syncytial variant nodular sclerosis Hodgkin lymphoma.	PAX5
34872475	10.2174/1566524021666211206094046	2022	PAX5 Haploinsufficiency Induces Low T Cell Infiltration in the Cancer Microenvironment via Reduced Chemokines.	PAX5
34896889	10.1016/j.anndiagpath.2021.151868	2022	Merkel cell carcinoma in the setting of hematologic disease is associated with unique features and potential pitfalls.	PAX5
34907175	10.1038/s41467-021-27197-5	2022	Interleukin-7 receptor α mutational activation can initiate precursor B-cell acute lymphoblastic leukemia.	PAX5
34910327	10.1111/jop.13269	2022	Oral versus extra-oral plasmablastic lymphoma: A comparative analysis of 101 cases.	PAX5
34924212	10.1016/j.pathol.2021.09.019	2022	Monocytoid switch in an adult with B-cell precursor acute lymphoblastic leukaemia characterised by the PAX5 P80R mutation.	PAX5
34933343	10.1182/bloodadvances.2021005634	2022	Whole-transcriptome analysis in acute lymphoblastic leukemia: a report from the DFCI ALL Consortium Protocol 16-001.	PAX5
34940123	10.3390/cimb43030149	2022	Molecular Genetics of Pre-B Acute Lymphoblastic Leukemia Sister Cell Lines during Disease Progression.	PAX5
34957727	10.2478/raon-2021-0050	2022	Clinical impacts of copy number variations in B-cell differentiation and cell cycle control genes in pediatric B-cell acute lymphoblastic leukemia: a single centre experience.	PAX5
34981542	10.1111/cup.14196	2022	Immunohistochemistry of the oncofetal protein IMP3 is helpful in the diagnosis of intravascular large B-cell lymphoma using skin biopsy.	PAX5
35004601	10.3389/fpubh.2021.805757	2022	Risk Factors for Childhood Leukemia: Radiation and Beyond.	PAX5
35011638	10.3390/cells11010076	2022	Pax-5 Protein Expression Is Regulated by Transcriptional 3'UTR Editing.	PAX5
35013921	10.1007/s12029-021-00790-z	2022	Spindle Variant Primary Diffuse Large B Cell Lymphoma of the Colon: Case Report and Literature Review.	PAX5
35067515	10.1097/PAS.0000000000001828	2022	Composite Classic Hodgkin Lymphoma and Follicular Lymphoma: A Clinicopathologic Study of 22 Cases With Review of 27 Additional Cases in the Literature.	PAX5
35091549	10.1038/s41408-022-00616-6	2022	Chronic lymphocytic leukemia (CLL) with Reed-Sternberg-like cells vs Classic Hodgkin lymphoma transformation of CLL: does this distinction matter?	PAX5
35131871	10.1158/0008-5472.CAN-21-3386	2022	Transient Inhibition of the JAK/STAT Pathway Prevents B-ALL Development in Genetically Predisposed Mice.	PAX5
35179642	10.1007/s00277-021-04394-2	2022	CD20/CD79a/PAX5/CD3-negative post-transplant lymphoma with aberrant actin and desmin co-expression-a potential differential diagnostic pitfall between PTLD and PTSMT.	PAX5
35192684	10.1182/blood.2022015444	2022	Enhancer retargeting of CDX2 and UBTF::ATXN7L3 define a subtype of high-risk B-progenitor acute lymphoblastic leukemia.	PAX5
35205758	10.3390/cancers14041010	2022	Low Mutational Burden of Extranodal Marginal Zone Lymphoma of Mucosa-Associated Lymphoid Tissue in Patients with Primary Sjogren's Syndrome.	PAX5
35226982	10.31083/j.fbl2702039	2022	Cytofluorimetric assay to investigate variability in blinatumomab <i>in vitro</i> response.	PAX5
35231988	10.3760/cma.j.issn.0253-2727.2022.01.005	2022	[Mutational spectrum and its prognostic significance in childhood acute lymphoblastic leukemia based on next-generation sequencing technology].	PAX5
35245931	10.1182/bloodadvances.2021006328	2022	Characterization of PAX5 intragenic tandem multiplication in pediatric B-lymphoblastic leukemia by optical genome mapping.	PAX5
35264043	10.1177/10406387221078608	2022	Pax5 and CD3 immunophenotyping of lymphoma in 2 central bearded dragons.	PAX5
35264486	10.11405/nisshoshi.119.227	2022	[Endoscopic mucosal resection of localized plasmablastic lymphoma with early rectal cancer:a rare case report and literature review].	PAX5
35286176	10.1080/15513815.2022.2050325	2022	A Curious Case of Morphologically Deceptive Pediatric B-Lymphoblastic Leukemia with Granular Blebbed Blasts and DLBCL-Like Biopsy Findings.	PAX5
35307403	10.1016/j.humpath.2022.03.005	2022	CD3-and CD20-negative extramedullary non-Hodgkin leukemia/lymphoma: a histopathological study of 118 cases.	PAX5
35322462	10.1111/his.14652	2022	Epstein-Barr virus infection patterns in nodular lymphocyte-predominant Hodgkin lymphoma.	PAX5
35395675	10.1093/carcin/bgac034	2022	Genomic profile of radiation-induced early-onset mouse B-cell lymphoma recapitulates features of Philadelphia chromosome-like acute lymphoblastic leukemia in humans.	PAX5
35409379	10.3390/ijms23074021	2022	Hypermethylation-Mediated Silencing of <i>CIDEA</i>, <i>MAL</i> and <i>PCDH17</i> Tumour Suppressor Genes in Canine DLBCL: From Multi-Omics Analyses to Mechanistic Studies.	PAX5
35442117	10.1177/10406387221090281	2022	Primary nervous system lymphoma in cats.	PAX5
35448666	10.3390/vetsci9040168	2022	Bcl-2 Immunoexpression in Feline Epitheliotropic Intestinal T-Cell Lymphomas.	PAX5
35460405	10.1093/ajcp/aqac044	2022	IRF8 as a Novel Marker to Differentiate Between CD30-Positive Large Cell Lymphomas.	PAX5
35467057	10.1111/cas.15380	2022	PAX5 alterations in an infant case of KMT2A-rearranged leukemia with lineage switch.	PAX5
35512254	10.1093/ajcp/aqab179	2022	The Effectiveness of Dual-Staining Immunohistochemistry in the Detection of Mantle Cell Lymphoma in the Bone Marrow.	PAX5
35521914	10.1177/10668969221099627	2022	ALK-positive Large B-Cell Lymphoma Presenting as a Circumscribed Breast Mass with Germinal Center Immunophenotype.	PAX5
35523507	10.1136/bcr-2021-247430	2022	Epstein-Barr virus-positive mucocutaneous ulcer, plasmablastic type, associated with nodal CD4+ angioimmunoblastic T-cell lymphoma and generalised pruritus: a self-limiting lymphoproliferative disorder resembling cutaneous plasmablastic lymphoma.	PAX5
35562413	10.1038/s41379-022-01091-x	2022	Human herpesvirus 8-negative effusion-based large B-cell lymphoma: a distinct entity with unique clinicopathologic characteristics.	PAX5
35562965	10.3390/ijms23094574	2022	Multi-Cohort Transcriptomic Subtyping of B-Cell Acute Lymphoblastic Leukemia.	PAX5
35575765	10.1097/PAS.0000000000001917	2022	Nodular Lymphocyte-predominant Hodgkin Lymphoma With Nodular Sclerosis: An Underrecognized Feature Associated With Pattern D.	PAX5
35600178	10.1016/j.amsu.2022.103786	2022	Immunohistochemical expression of transcription factors PAX5, OCT2, BCL6 and transcription regulator P53 in Non-Hodgkin lymphomas: A diagnostic cross-sectional study.	PAX5
35646671	10.3389/fonc.2022.883141	2022	Case Report: Intravascular Large B-Cell Lymphoma: A Clinicopathologic Study of Four Cases With Review of Additional 331 Cases in the Literature.	PAX5
35664405	10.7759/cureus.24592	2022	Primary Endometrial Diffuse Large B-cell Lymphoma: A Rare Disease and Diagnostic Challenge in an Asymptomatic Postmenopausal Woman.	PAX5
35673721	10.3760/cma.j.cn112151-20211117-00836	2022	[ALK-positive large B-cell lymphoma with EBV infection or cyclin D1 expression: a clinicopathological analysis of 3 cases].	PAX5
35774514	10.3389/fgene.2022.827840	2022	A Novel Defined Super-Enhancer Associated Gene Signature to Predict Prognosis in Patients With Diffuse Large B-Cell Lymphoma.	PAX5
35789115	10.1111/his.14718	2022	Hodgkinoid histiocytosis: an atypical nodal CD30 and S100-positive histiocytosis with eosinophilia.	PAX5
35864305	10.1038/s41698-022-00295-3	2022	Peripheral blood DNA methylation profiles predict future development of B-cell Non-Hodgkin Lymphoma.	PAX5
35911381	10.3389/fmed.2022.896647	2022	Thymic Extranodal Marginal-Zone Lymphoma of Mucosa-Associated Lymphoid Tissue: Pathological Features, <sup>18</sup>F-FDG PET/CT Findings and Prognosis in 12 Cases.	PAX5
35920299	10.1096/fj.202200061RR	2022	Mcm2 hypomorph leads to acute leukemia or hematopoietic stem cell failure, dependent on genetic context.	PAX5
35926290	10.1016/j.anndiagpath.2022.151974	2022	The utility of PAX8 in comparison with PAX5 immunohistochemical staining in the diagnosis of Hodgkin lymphoma.	PAX5
35949809		2022	Transient atypical lymphoplasmacytic proliferation of the endometrium associated with pyometra: a case report.	PAX5
35977101	10.1182/blood.2022016056	2022	Discovery of novel predisposing coding and noncoding variants in familial Hodgkin lymphoma.	PAX5
35979119	10.12998/wjcc.v10.i17.5708	2022	Gray zone lymphoma effectively treated with cyclophosphamide, doxorubicin, vincristine, prednisolone, and rituximab chemotherapy: A case report.	PAX5
35987347	10.1016/j.humpath.2022.07.024	2022	EBV-positive nodular lymphocyte predominant Hodgkin lymphoma: a single institution experience.	PAX5
36032657	10.3389/pore.2022.1610482	2022	The Prognostic Value of Eight Immunohistochemical Markers Expressed in the Tumor Microenvironment and on Hodgkin Reed-Sternberg Cells in Pediatric Patients With Classical Hodgkin Lymphoma.	PAX5
36077495	10.3390/ijms231710095	2022	The Pleiotropy of <i>PAX5</i> Gene Products and Function.	PAX5
31935288	10.1182/bloodadvances.2019000947	2021	Expression of the prosurvival kinase HCK requires PAX5 and mutated MYD88 signaling in MYD88-driven B-cell lymphomas.	PAX5
32161948	10.1093/gigascience/giaa016	2021	An image dataset related to automated macrophage detection in immunostained lymphoma tissue samples.	PAX5
32202217	10.1177/0300985820906889	2021	Equine Intestinal Lymphoma: Clinical-Pathological Features, Immunophenotype, and Survival.	PAX5
32202225	10.1177/0300985820913265	2021	Spectrum of Posttransplant Lymphoproliferations in NSG Mice and Their Association With EBV Infection After Engraftment of Pediatric Solid Tumors.	PAX5
32235787	10.3390/ijms21062193	2021	The Current Genomic and Molecular Landscape of Philadelphia-like Acute Lymphoblastic Leukemia.	PAX5
32245383	10.1186/s12920-020-0709-y	2021	Comprehensive chromosomal aberrations in a case of a patient with TCF3-HLF-positive BCP-ALL.	PAX5
32368831	10.1002/gcc.22858	2021	Impact of immunophenotypic characteristics on genetic subgrouping in childhood acute lymphoblastic leukemia: Tokyo Children's Cancer Study Group (TCCSG) study L04-16.	PAX5
32420699	10.1002/cam4.3136	2021	Serine-227 in the N-terminal kinase domain of RSK2 is a potential therapeutic target for mantle cell lymphoma.	PAX5
32590454	10.1097/PAI.0000000000000863	2021	Aberrant Cytoplasmic Terminal Deoxynucleotidyl Transferase (TdT) Immunostaining on Previously Frozen, Formalin-fixed Paraffin-embedded Tissue: Cryotomy-induced Antigen Diffusion (CIAD).	PAX5
32592278	10.1002/gcc.22882	2021	Frequency and prognostic impact of PAX5 p.P80R in pediatric acute lymphoblastic leukemia patients treated on an AIEOP-BFM acute lymphoblastic leukemia protocol.	PAX5
32622430	10.1016/j.acthis.2020.151548	2021	Identification of aspartame-induced haematopoietic and lymphoid tumours in rats after lifetime treatment.	PAX5
32646889	10.3324/haematol.2020.250423	2021	DUX4r, ZNF384r and PAX5-P80R mutated B-cell precursor acute lymphoblastic leukemia frequently undergo monocytic switch.	PAX5
32684618	10.12659/AJCR.921840	2021	Primary Isolated Lymphoplasmacytic Lymphoma (LPL) of the Stomach: A Case Report.	PAX5
32693409	10.1182/blood.2020006164	2021	Molecular basis of ETV6-mediated predisposition to childhood acute lymphoblastic leukemia.	PAX5
32731299	10.1111/bjh.17002	2021	High-risk B-cell acute lymphoblastic leukaemia presenting with hypereosinophilia and acquiring a novel PAX5 fusion on relapse.	PAX5
32769356	10.4103/IJPM.IJPM_343_18	2021	High-grade transformation in nodular lymphocyte predominant Hodgkin lymphoma.	PAX5
32911536	10.1182/blood.2019004381	2021	An intact gut microbiome protects genetically predisposed mice against leukemia.	PAX5
32991677	10.5858/arpa.2020-0135-OA	2021	CD20-Negative Nodular Lymphocyte-Predominant Hodgkin Lymphoma: A 20-Year Consecutive Case Series From a Tertiary Cancer Center.	PAX5
33004416	10.1101/gad.340216.120	2021	EBF1 and Pax5 safeguard leukemic transformation by limiting IL-7 signaling, Myc expression, and folate metabolism.	PAX5
33036026	10.1182/blood.2020005756	2021	Germline PAX5 mutation predisposes to familial B-cell precursor acute lymphoblastic leukemia.	PAX5
33038982	10.1016/j.beha.2020.101193	2021	Molecular markers in ALL: Clinical implications.	PAX5
33079423	10.1111/pin.13038	2021	Mantle cell lymphoma with EBV-positive Hodgkin and Reed-Sternberg-like cells in a patient after autologous PBSCT: Phenotypically distinct but genetically related tumors.	PAX5
33094664	10.1080/15476286.2020.1838783	2021	LncRNAs in adaptive immunity: role in physiological and pathological conditions.	PAX5
33154497	10.1038/s41598-020-76206-y	2021	Inhibition of inflammatory signaling in Pax5 mutant cells mitigates B-cell leukemogenesis.	PAX5
33206936	10.1182/blood.2020005650	2021	Genomic and transcriptomic correlates of Richter transformation in chronic lymphocytic leukemia.	PAX5
33357483	10.1016/S2352-3026(20)30353-7	2021	Outcomes of paediatric patients with B-cell acute lymphocytic leukaemia with ABL-class fusion in the pre-tyrosine-kinase inhibitor era: a multicentre, retrospective, cohort study.	PAX5
33369444	10.31557/APJCP.2020.21.12.3493	2021	Frequency and Correlation of Common Genes Copy Number Alterations in Childhood Acute Lymphoblastic Leukemia with Prognosis.	PAX5
33400146	10.1007/s11684-020-0821-6	2021	Emerging molecular subtypes and therapeutic targets in B-cell precursor acute lymphoblastic leukemia.	PAX5
33427203		2021	Primary diffuse large B cell lymphoma of the lactating left breast. A case report and review of the literature.	PAX5
33452395	10.1038/s41598-021-81000-5	2021	EBF1 drives hallmark B cell gene expression by enabling the interaction of PAX5 with the MLL H3K4 methyltransferase complex.	PAX5
33480087	10.1002/hon.2839	2021	High-grade B-cell lymphomas with MYC and BCL2 translocations lack tumor-associated macrophages and PD-L1 expression: A possible noninflamed subgroup.	PAX5
33528622	10.1007/s00428-021-03022-8	2021	Mantle cell lymphomas with concomitant MYC and CCND1 breakpoints are recurrently TdT positive and frequently show high-grade pathological and genetic features.	PAX5
33531346	10.1073/pnas.2016553118	2021	PON2 subverts metabolic gatekeeper functions in B cells to promote leukemogenesis.	PAX5
33538150	10.3324/haematol.2020.260935	2021	A multicenter total therapy strategy for <i>de novo</i> adult Philadelphia chromosome positive acute lymphoblastic leukemia patients: final results of the GIMEMA LAL1509 protocol.	PAX5
33550334		2021	[Clinicopathological analysis of mucosa associated lymphoid tissue lymphoma secondary to Sjögren' s syndrome in salivary gland].	PAX5
33570645	10.1182/bloodadvances.2020003201	2021	Clinicopathological features of adult T-cell leukemia/lymphoma with HTLV-1-infected Hodgkin and Reed-Sternberg-like cells.	PAX5
33585230	10.3389/fonc.2020.609839	2021	Whole-Exome Sequencing Reveals New Potential Mutations Genes for Primary Mucosa-Associated Lymphoid Tissue Lymphoma Arising From the Kidney.	PAX5
33619557	10.1182/blood.2020009564	2021	EBF1 and PAX5 control pro-B cell expansion via opposing regulation of the Myc gene.	PAX5
33686443	10.2340/00015555-3775	2021	Role of B-cells in Mycosis Fungoides.	PAX5
33716241	10.3960/jslrt.20052	2021	Follicular T-cell lymphoma mimicking lymphocyte-rich classic Hodgkin lymphoma: a case report of a diagnostic pitfall.	PAX5
33750258	10.1080/0284186X.2021.1900908	2021	Genomic landscape of B-other acute lymphoblastic leukemia in an adult retrospective cohort with a focus on <i>BCR-ABL1</i>-like subtype.	PAX5
33789373	10.3760/cma.j.cn112137-20201014-02831	2021	[Transcriptome sequencing-based classification and quantification of IKZF1 transcript isoforms in B-cell acute lymphoblastic leukemia].	PAX5
33813951	10.1177/03009858211002180	2021	Lymphoma in Psittacine Birds: A Histological and Immunohistochemical Assessment.	PAX5
33816589	10.3389/fvets.2021.647009	2021	Phenotypical Characterization and Clinical Outcome of Canine Burkitt-Like Lymphoma.	PAX5
33895809	10.1182/blood.2020010144	2021	Molecular classification improves risk assessment in adult BCR-ABL1-negative B-ALL.	PAX5
34099776	10.1038/s41598-021-91433-7	2021	Prognostic significance of p53, Sox11, and Pax5 co-expression in mantle cell lymphoma.	PAX5
34342935	10.1111/ijlh.13671	2021	Bone marrow trephine immunohistochemistry is useful in characterizing malignancy-associated myelonecrosis: A retrospective observational study.	PAX5
34350085	10.7759/cureus.16128	2021	Treatment of Primary Mediastinal B-Cell Lymphoma With R-CEOP (Rituximab, Cyclophosphamide, Etoposide, Vincristine, and Prednisone).	PAX5
34406703	10.1002/ajh.26324	2021	The clinical outcomes and genomic landscapes of acute lymphoblastic leukemia patients with E2A-PBX1: A 10-year retrospective study.	PAX5
34484175	10.3389/fimmu.2021.670280	2021	Forward and Reverse Genetics of B Cell Malignancies: From Insertional Mutagenesis to CRISPR-Cas.	PAX5
34499929	10.1016/j.lfs.2021.119932	2021	PAX5-activated lncRNA ARRDC1-AS1 accelerates the autophagy and progression of DLBCL through sponging miR-2355-5p to regulate ATG5.	PAX5
34511545	10.3960/jslrt.21008	2021	Lymphocyte-depleted classic Hodgkin lymphoma with primary extranodal disease: Two cases that highlight the combination of immunodeficiency and immune escape in the pathogenesis.	PAX5
34535769	10.1038/s41388-021-02012-z	2021	Identification of mutations that cooperate with defects in B cell transcription factors to initiate leukemia.	PAX5
34868769	10.7759/cureus.19130	2021	Adult Nodal Burkitt Lymphoma Forming Nodular Architectures.	PAX5
34877288	10.12998/wjcc.v9.i31.9542	2021	Clinical observation of pediatric-type follicular lymphomas in adult: Two case reports.	PAX5
34944954	10.3390/cancers13246334	2021	Impact of a Faulty Germinal Center Reaction on the Pathogenesis of Primary Diffuse Large B Cell Lymphoma of the Central Nervous System.	PAX5
25599090	10.9734/IJMPCR/2015/13625	2020	EBV-Positive Grey Zone Lymphoma in an HIV Infected Man from Kampala, Uganda: Case Report.	PAX5
28078156	10.1155/2016/3291549	2020	Undifferentiated Malignant Neoplasm Involving Parotid and Thyroid: Sampling and PAX8 Cross-Reactivity Can Obscure the Diagnosis of Lymphoma.	PAX5
28487787	10.1155/2017/5083463	2020	EBV-Negative Monomorphic B-Cell Posttransplant Lymphoproliferative Disorder with Marked Morphologic Pleomorphism and Pathogenic Mutations in <i>ASXL1</i>, <i>BCOR</i>, <i>CDKN2A</i>, <i>NF1</i>, and <i>TP53</i>.	PAX5
28579851	10.1177/1179545X17692544	2020	Transformation of Follicular Lymphoma to a High-Grade B-Cell Lymphoma With MYC and BCL2 Translocations and Overlapping Features of Burkitt Lymphoma and Acute Lymphoblastic Leukemia: A Case Report and Literature Review.	PAX5
29109877	10.1155/2017/7531729	2020	PAX5-Negative Classical Hodgkin Lymphoma: A Case Report of a Rare Entity and Review of the Literature.	PAX5
29344502	10.1159/000478747	2020	Orbital Epstein-Barr Virus-Positive Polymorphic B-Cell Lymphoproliferative Disorder in an Apparently Immunocompetent Woman.	PAX5
29379600		2020	PAX-5 positive anaplastic large cell lymphoma presenting by dysphagia; a case report.	PAX5
29379791	10.3389/fvets.2017.00245	2020	MicroRNAs Encoded by Bovine Leukemia Virus (BLV) Are Associated with Reduced Expression of B Cell Transcriptional Regulators in Dairy Cattle Naturally Infected with BLV.	PAX5
29805352	10.1159/000486190	2020	Hemophagocytic Lymphohistiocytosis Secondary to Unknown Underlying Hodgkin Lymphoma Presenting with a Cholestatic Pattern of Liver Injury.	PAX5
29931583	10.1007/s10637-018-0623-8	2020	Dual targeting of bromodomain-containing 4 by AZD5153 and BCL2 by AZD4320 against B-cell lymphomas concomitantly overexpressing c-MYC and BCL2.	PAX5
30190342	10.3324/haematol.2018.196055	2020	Prognostic implications of additional genomic lesions in adult Philadelphia chromosome-positive acute lymphoblastic leukemia.	PAX5
30532056	10.1038/s41409-018-0419-7	2020	PAX5, NOTCH3, CBFB, and ACD drive an activated RAS pathway and monosomy 7 to B-ALL and AML in donor cell leukemia.	PAX5
30540571	10.1097/PAS.0000000000001198	2020	Gray-zone Lymphoma Between cHL and Large B-Cell Lymphoma: A Histopathologic Series From the LYSA.	PAX5
30630978	10.3324/haematol.2018.204974	2020	Genomic landscape of pediatric B-other acute lymphoblastic leukemia in a consecutive European cohort.	PAX5
30874617	10.1038/s41598-019-41078-4	2020	Copy number alterations in B-cell development genes, drug resistance, and clinical outcome in pediatric B-cell precursor acute lymphoblastic leukemia.	PAX5
30940639	10.1182/bloodadvances.2018030635	2020	Germline deletion of <i>ETV6</i> in familial acute lymphoblastic leukemia.	PAX5
30946100	10.1097/DAD.0000000000001422	2020	Clear Cell Primary Cutaneous Anaplastic Large Cell Lymphoma.	PAX5
31000522	10.1158/0008-5472.CAN-18-3438	2020	MDM4 Is Targeted by 1q Gain and Drives Disease in Burkitt Lymphoma.	PAX5
31170889	10.1177/0300985819852138	2020	Immunophenotyping of Murine Precursor B-Cell Leukemia/Lymphoma: A Comparison of Immunohistochemistry and Flow Cytometry.	PAX5
31202078	10.1016/j.leukres.2019.05.013	2020	Microarray testing as an efficient tool to redefine hyperdiploid paediatric B-cell precursor acute lymphoblastic leukaemia patients.	PAX5
31215109	10.1111/pin.12800	2020	A fulminant case of classical Hodgkin lymphoma: A diagnostic dilemma of Epstein-Barr virus-positive large B-cell neoplasms.	PAX5
31228652	10.1016/j.leukres.2019.05.009	2020	Prognostic gene alterations and clonal changes in childhood B-ALL.	PAX5
31311817	10.1182/blood.2018852400	2020	Genetic defects in hematopoietic transcription factors and predisposition to acute lymphoblastic leukemia.	PAX5
31347181	10.1111/vcp.12759	2020	Optimized immunocytochemistry using leukocyte and tissue markers on Romanowsky-stained slides from dogs and cats.	PAX5
31360094	10.2147/BLCTT.S142814	2020	Plasmablastic lymphoma: current perspectives.	PAX5
31361906	10.1111/his.13964	2020	Extraoral plasmablastic lymphomas in a high human immunodeficiency virus endemic area.	PAX5
31381561	10.1371/journal.pgen.1008280	2020	PAX5 is part of a functional transcription factor network targeted in lymphoid leukemia.	PAX5
31441945	10.1111/cup.13571	2020	Concurrent cutaneous localization of Langerhans cell sarcoma and chronic lymphocytic leukemia/small lymphocytic lymphoma in a patient with a history of chronic lymphocytic leukemia/small lymphocytic lymphoma.	PAX5
31565620	10.7759/cureus.5217	2020	CD-20 Negative Plasmablastic Lymphoma Lurking in the Shadow of a Leiomyoma - Diagnosis and Management.	PAX5
31605845	10.1016/j.wneu.2019.09.158	2020	Primary Intra-Axial Diffuse Large B-Cell Lymphoma in Immunocompetent Patients: Clinical Impact of Molecular Analysis and Histogenetic Evaluation.	PAX5
31622281	10.1172/jci.insight.131434	2020	A unique mutator phenotype reveals complementary oncogenic lesions leading to acute leukemia.	PAX5
31631721	10.1177/1066896919883013	2020	Primary Low-Grade B-Cell Lymphoma of Skull With Translocation Between Immunoglobulin and Interferon Regulatory Factor 4 Genes.	PAX5
31699300	10.1016/j.pathol.2019.09.005	2020	Hodgkin lymphoma: a review of pathological features and recent advances in pathogenesis.	PAX5
31721454	10.1002/prca.201900091	2020	Utility of a Reverse Phase Protein Array to Evaluate Multiple Biomarkers in Diffuse Large B-Cell Lymphoma.	PAX5
31779973	10.1016/j.beha.2019.101095	2020	How advanced are we in targeting novel subtypes of ALL?	PAX5
31784094	10.1016/j.prp.2019.152724	2020	ALK-negative anaplastic large cell lymphoma with Hodgkin-like cytomorphology and nuclear expression of PAX5.	PAX5
31788294	10.1002/ccr3.2444	2020	Merkel cell carcinoma mimicking transformed chronic lymphocytic leukemia/small lymphocytic lymphoma.	PAX5
31804490	10.1038/s41467-019-13570-y	2020	Infectious stimuli promote malignant B-cell acute lymphoblastic leukemia in the absence of AID.	PAX5
31811434	10.1007/s00428-019-02695-6	2020	Characterisation of tumour microenvironment and immune checkpoints in primary central nervous system diffuse large B cell lymphomas.	PAX5
31825183	10.1002/dc.24366	2020	CD15, CD30, and PAX5 evaluation in Hodgkin's lymphoma on fine-needle aspiration cytology samples.	PAX5
31837029	10.1111/vcp.12816	2020	Lymphoma with Mott cell differentiation and validation of immunohistochemical lymphoid markers in an African pygmy hedgehog (Atelerix albiventris).	PAX5
31882486	10.21873/invivo.11768	2020	Laryngeal Diffuse Large B-Cell Lymphoma Presenting as Laryngeal Stenosis.	PAX5
31882553	10.21873/cgp.20169	2020	BRD4-Regulated Molecular Targets in Mantle Cell Lymphoma: Insights into Targeted Therapeutic Approach.	PAX5
31894892	10.1111/pin.12888	2020	Syncytial variant of classic Hodgkin lymphoma: Four cases diagnosed with the aid of CD274/programmed cell death ligand 1 immunohistochemistry.	PAX5
31955451	10.1002/hon.2716	2020	Diffuse large B-cell lymphoma carrying t(9;14)(p13;q32)/PAX5-immunoglobulin heavy chain gene is characterized by nuclear positivity of MUM1 and PAX5 by immunohistochemistry.	PAX5
32023600	10.11406/rinketsu.61.33	2020	[CD20-negative diffuse large B-cell lymphoma complicated by rheumatoid arthritis].	PAX5
32078009	10.1007/s00277-020-03953-3	2020	Implementation of RNA sequencing and array CGH in the diagnostic workflow of the AIEOP-BFM ALL 2017 trial on acute lymphoblastic leukemia.	PAX5
32240660	10.1016/j.yexcr.2020.111986	2020	Establishment and characterization of a porcine B cell lymphoma cell line.	PAX5
32314054	10.1007/s00428-020-02776-x	2020	CD20-positive extranodal NK/T cell lymphoma: clinicopathologic and prognostic features.	PAX5
32486538	10.3760/cma.j.cn112151-20190929-00538	2020	[Mediastinal T lymphoblastic lymphoma/leukemia: clinicopathological and prognostic analyses of 61 cases].	PAX5
32543142	10.12182/20200560605	2020	[Relationship of Expression Between SOX11 and PAX5 in Pathological Tissue Specimens of Patients with Mantle Cell Lymphoma and Its Clinical Significance].	PAX5
32604737	10.3390/microorganisms8060958	2020	Variable Expression of Notch1 and Pax5 in Classical Hodgkin Lymphoma and Infection with Epstein-Barr in Pediatric Patients.	PAX5
32656633	10.1007/s12185-020-02944-4	2020	Functional analysis of a novel fusion protein PAX5-KIDINS220 identified in a pediatric Ph-like ALL patient.	PAX5
32661308	10.1038/s41598-020-68311-9	2020	MLPA and DNA index improve the molecular diagnosis of childhood B-cell acute lymphoblastic leukemia.	PAX5
32992415	10.3760/cma.j.cn112151-20200304-00168	2020	[Clinicopathological features in relapsed diffuse large B-cell lymphoma].	PAX5
32992416	10.3760/cma.j.cn112151-20200212-00081	2020	[CD20-positive T cell lymphoma: clinicopathological features of five cases].	PAX5
33067942	10.19746/j.cnki.issn.1009-2137.2020.05.010	2020	[Comparison of Pathological Immunohistochemical and Flow Immunotyping Results of Patients with Lymphoma Cell Leukemia and Its Clinical Significance].	PAX5
33085860	10.1056/NEJMoa2016272	2020	Dasatinib-Blinatumomab for Ph-Positive Acute Lymphoblastic Leukemia in Adults.	PAX5
33173488	10.1159/000510403	2020	High-Grade Epstein-Barr Virus-Negative Biphenotypic Lymphoma with Expression of B- and T-Cell Markers and Leukemia Presentation: Case Report and Literature Review.	PAX5
33283700	10.19746/j.cnki.issn.1009-2137.2020.06.001	2020	[Gene Mutation in Acute Lymphoblastic Leukemia by DNA Sequencing].	PAX5
33293491		2020	FISH is Still an Excellent Tool to Monitor High-Grade Lymphomas.	PAX5
33354553	10.1055/s-0040-1721194	2020	Plasmablastic Lymphoma: A Clinicopathological Study from a Tertiary Care Cancer Center in South India.	PAX5
26951888	10.1111/vcp.12343	2019	B-cell lymphoma with Mott cell differentiation in a cat.	PAX5
27170210	10.1111/pin.12417	2019	Epstein-Barr virus-positive diffuse large B cell lymphoma arising from a chronic lymphocytic leukemia: Overlapping features with classical Hodgkin lymphoma.	PAX5
27941564	10.1097/PAI.0000000000000473	2019	Paired Box 5 (PAX5) Expression in Poorly Differentiated Neuroendocrine Carcinoma of the Gastrointestinal and Pancreatobiliary Tract: Diagnostic and Potentially Therapeutic Implications.	PAX5
28959124		2019	Higher Expression of Activation-induced Cytidine Deaminase Is Significantly Associated with Merkel Cell Polyomavirus-negative Merkel Cell Carcinomas.	PAX5
29029550	10.18632/oncotarget.19271	2019	B lymphoblastic leukemia/lymphoma: new insights into genetics, molecular aberrations, subclassification and targeted therapy.	PAX5
29050074	10.3760/cma.j.issn.0529-5807.2017.10.010	2019	[Clinicopathologic characteristics and prognosis of neoplastic cell-rich mixed cellularity classic Hodgkin lymphoma].	PAX5
29112015	10.1097/PAS.0000000000000983	2019	PD-L1 and PD-L2 Are Differentially Expressed by Macrophages or Tumor Cells in Primary Cutaneous Diffuse Large B-Cell Lymphoma, Leg Type.	PAX5
29199525	10.1080/10428194.2017.1408087	2019	Molecular genetic profile in BCR-ABL1 negative pediatric B-cell acute lymphoblastic leukemia can further refine outcome prediction in addition to that by end-induction minimal residual disease detection.	PAX5
29327711	10.1038/modpathol.2017.177	2019	CD3-positive plasmablastic B-cell neoplasms: a diagnostic pitfall.	PAX5
29348129	10.1182/blood-2017-07-796862	2019	Genomic CDKN2A/2B deletions in adult Ph<sup>+</sup> ALL are adverse despite allogeneic stem cell transplantation.	PAX5
29390075	10.1093/nar/gky057	2019	IW-Scoring: an Integrative Weighted Scoring framework for annotating and prioritizing genetic variations in the noncoding genome.	PAX5
29407587	10.1016/j.leukres.2018.01.012	2019	High frequency of intermediate and poor risk copy number abnormalities in pediatric cohort of B-ALL correlate with high MRD post induction.	PAX5
29453973	10.1016/j.yexcr.2018.02.010	2019	PAX5 haploinsufficiency induce cancer cell dormancy in Raji cells.	PAX5
29490943	10.1158/0008-5472.CAN-17-3262	2019	Loss of Pax5 Exploits Sca1-BCR-ABL<sup>p190</sup> Susceptibility to Confer the Metabolic Shift Essential for pB-ALL.	PAX5
29498923	10.1200/JCO.2017.74.3617	2019	IKZF1<sup>plus</sup> Defines a New Minimal Residual Disease-Dependent Very-Poor Prognostic Profile in Pediatric B-Cell Precursor Acute Lymphoblastic Leukemia.	PAX5
29507076	10.1182/bloodadvances.2017014704	2019	Prognostic impact of kinase-activating fusions and IKZF1 deletions in pediatric high-risk B-lineage acute lymphoblastic leukemia.	PAX5
29551267	10.1016/j.cell.2018.02.048	2019	B-Cell-Specific Diversion of Glucose Carbon Utilization Reveals a Unique Vulnerability in B Cell Malignancies.	PAX5
29641322	10.1089/hum.2017.207	2019	Preclinical Efficacy and Safety of CD19CAR Cytokine-Induced Killer Cells Transfected with Sleeping Beauty Transposon for the Treatment of Acute Lymphoblastic Leukemia.	PAX5
30214688	10.18632/oncotarget.26003	2019	<i>PAX5A</i> and <i>PAX5B</i> isoforms are both efficient to drive B cell differentiation.	PAX5
30216339	10.1371/journal.pgen.1007642	2019	Activating PAX gene family paralogs to complement PAX5 leukemia driver mutations.	PAX5
30253384	10.1159/000492146	2019	Chimeric Antigen Receptor-T Cells with 4-1BB Co-Stimulatory Domain Present a Superior Treatment Outcome than Those with CD28 Domain Based on Bioinformatics.	PAX5
30286705	10.1177/0300985818806059	2019	Canine Cerebral Intravascular Lymphoma: Neuropathological and Immunohistochemical Findings.	PAX5
30308041	10.1371/journal.pone.0205537	2019	NKL homeobox gene activities in B-cell development and lymphomas.	PAX5
30358180	10.1111/vcp.12668	2019	Validation of an immunocytochemical assay for immunophenotyping of lymphoma in guinea pigs (Cavia porcellus).	PAX5
30370547	10.1111/cup.13382	2019	Cutaneous localization of angioimmunoblastic T-cell lymphoma may masquerade as B-cell lymphoma or classical Hodgkin lymphoma: A histologic diagnostic pitfall.	PAX5
30425960	10.4314/ovj.v8i4.3	2019	Morphological characterization of canine retrobulbar lymphoma.	PAX5
30474245	10.1111/vde.12703	2019	Prevalence of CD20<sup>+</sup> cutaneous epitheliotropic T-cell lymphoma in dogs: a retrospective analysis of 24 cases (2011-2018) in the USA.	PAX5
30478446	10.1038/s41388-018-0573-9	2019	Chromosomal translocation-mediated evasion from miRNA induces strong MEF2D fusion protein expression, causing inhibition of PAX5 transcriptional activity.	PAX5
30487223	10.1073/pnas.1814397115	2019	Transcriptional landscape of B cell precursor acute lymphoblastic leukemia based on an international study of 1,223 cases.	PAX5
30510083	10.1182/blood-2018-10-882142	2019	<i>PAX5</i> P80R mutation identifies a novel subtype of B-cell precursor acute lymphoblastic leukemia with favorable outcome.	PAX5
30534553	10.1155/2018/1042597	2019	Bone Marrow Molecular Markers Associated with Relapsed/Refractory Activated B-Cell-Like Diffuse Large B-Cell Lymphoma.	PAX5
30561032	10.1111/jvim.15398	2019	Myoclonus and hypercalcemia in a dog with poorly differentiated lymphoproliferative neoplasia.	PAX5
30563523	10.1186/s12920-018-0444-9	2019	A novel PAX5 rearrangement in TCF3-PBX1 acute lymphoblastic leukemia: a case report.	PAX5
30583670	10.31557/APJCP.2018.19.12.3463	2019	Expression of PAX-5 in B Cell Hodgkin and Non Hodgkin Lymphoma	PAX5
30643249	10.1038/s41588-018-0315-5	2019	PAX5-driven subtypes of B-progenitor acute lymphoblastic leukemia.	PAX5
30664812	10.1002/ijc.32144	2019	Tumor CD73/A2aR adenosine immunosuppressive axis and tumor-infiltrating lymphocytes in diffuse large B-cell lymphoma: correlations with clinicopathological characteristics and clinical outcome.	PAX5
30802809	10.1016/j.anndiagpath.2019.02.001	2019	American Registry of Pathology Expert Opinions: Immunohistochemical evaluation of classic Hodgkin lymphoma.	PAX5
30842609	10.1038/s41375-019-0430-z	2019	PAX5 biallelic genomic alterations define a novel subgroup of B-cell precursor acute lymphoblastic leukemia.	PAX5
30865320	10.1111/vcp.12709	2019	The cell tube block technique and an immunohistochemistry panel including Wilms tumor 1 to assist in diagnosing cavitary effusions in dogs and cats.	PAX5
30897306	10.1002/dc.24174	2019	A BAFfling liver aspirate: Metastatic high grade SMARCA4 deficient undifferentiated gastroesophageal junction carcinoma masquerading as a hematolymphoid malignancy.	PAX5
30963474	10.1007/s12185-019-02646-6	2019	Double-hit pancreatic B-lymphoblastic lymphoma with a variant translocation t(2;18)(p11;q21).	PAX5
31112375	10.1111/ijlh.13052	2019	Chromosomal microarray analysis is superior in identifying cryptic aberrations in patients with acute lymphoblastic leukemia at diagnosis/relapse as a single assay.	PAX5
31391365	10.11406/rinketsu.60.773	2019	[Philadelphia chromosome-positive acute lymphoblastic leukemia with basophilic blast features].	PAX5
31607324	10.19746/j.cnki.issn.1009-2137.2019.05.042	2019	[Deubiquitinase MYSM1 Regulates Differentiation of Human B Cells to Plasma Cells].	PAX5
26354309	10.1177/0300985815604724	2018	CD3 and CD20 Coexpression in a Case of Canine Cutaneous Epitheliotropic T-Cell Lymphoma (Mycosis Fungoides).	PAX5
27220664	10.1038/leu.2016.152	2018	Inhibition of precursor B-cell malignancy progression by toll-like receptor ligand-induced immune responses.	PAX5
27339065	10.1080/10428194.2016.1193855	2018	Gene copy number alteration profile and its clinical correlation in B-cell acute lymphoblastic leukemia.	PAX5
27374484	10.1080/17843286.2016.1201629	2018	Plasmablastic transformation of plasma cell myeloma with heterotropic expression of CD3 and CD4: a case report.	PAX5
27460500	10.1038/ncomms12320	2018	CD19 CAR immune pressure induces B-precursor acute lymphoblastic leukaemia lineage switch exposing inherent leukaemic plasticity.	PAX5
27549353	10.1111/vco.12262	2018	Evaluation of Pax5 expression and comparison with BLA.36 and CD79αcy in feline non-Hodgkin lymphoma.	PAX5
27756164	10.1080/10428194.2016.1228925	2018	Biallelic loss of CDKN2A is associated with poor response to treatment in pediatric acute lymphoblastic leukemia.	PAX5
28013563	10.1177/1066896916683447	2018	PAX-5 Positivity in Anaplastic Lymphoma Kinase-Negative Anaplastic Large Cell Lymphoma: A Case Report and Review of Literature.	PAX5
28183747	10.1182/blood-2016-10-745802	2018	T-cell rosettes in nodular lymphocyte-predominant Hodgkin lymphoma.	PAX5
28382853	10.1177/1040638717704239	2018	Primary cerebellar lymphoma with Hodgkin lymphoma-like morphology in a cat.	PAX5
28390747	10.1016/j.jaut.2017.03.012	2018	FcRL4<sup>+</sup> B-cells in salivary glands of primary Sjögren's syndrome patients.	PAX5
28446319	10.7534/j.issn.1009-2137.2017.02.053	2018	[Progress on Treatment of Splenic Marginal Zone Lymphoma-Review].	PAX5
28484276	10.1038/s41598-017-01800-6	2018	Tumor protein 53 mutations are enriched in diffuse large B-cell lymphoma with irregular CD19 marker expression.	PAX5
28631637	10.4103/IJPM.IJPM_466_16	2018	An integrated genomic profile that includes copy number alterations is highly predictive of minimal residual disease status in childhood precursor B-lineage acute lymphoblastic leukemia.	PAX5
28667038		2018	Post-transplant Lymphoproliferative Disorder Presented in a Form of Primary Effusion Lymphoma with t (8; 14).	PAX5
28730642	10.1111/his.13316	2018	MYC expression and translocation analyses in low-grade and transformed follicular lymphoma.	PAX5
28804091	10.1292/jvms.17-0317	2018	Hodgkin's-like lymphoma in a ferret (Mustela putorius furo).	PAX5
28806978	10.1186/s13045-017-0515-y	2018	Transcriptome sequencing in pediatric acute lymphoblastic leukemia identifies fusion genes associated with distinct DNA methylation profiles.	PAX5
28886309	10.14715/cmb/2017.63.8.4	2018	The correlation between Pax5 deletion and patients survival in Iranian children with precursor B-cell acute lymphocytic leukemia.	PAX5
28976132		2018	Diffuse large B cell lymphoma of hard palate: a case report with literature review.	PAX5
28982264	10.1177/1066896917735170	2018	De Novo Unclassifiable CD20-Negative Diffuse Large B-Cell Lymphoma: A Diagnostic and Therapeutic Challenge.	PAX5
29132472		2018	[Research progress in Ph-like childhood acute lymphoblastic leukemia].	PAX5
29154209	10.1016/j.molimm.2017.11.011	2018	External signals regulate germinal center fate-determining transcription factors in the A20 lymphoma cell line.	PAX5
29262892	10.7534/j.issn.1009-2137.2017.06.013	2018	[Transcription Factor Pax5 Promotes B-lymphomagenesis in a Promoter-Independent Manner].	PAX5
29325247	10.3760/cma.j.issn.0529-5807.2018.01.006	2018	[Impact of PRDM1 gene inactivation on C-MYC regulation in diffuse large B-cell lymphoma].	PAX5
29325249	10.3760/cma.j.issn.0529-5807.2018.01.008	2018	[Clinicopathologic features of primary hepatic marginal zone lymphoma of mucosa-associated lymphoid tissue and hepatic pseudolymphoma].	PAX5
29343197	10.1177/0300985817747326	2018	Coexpression of CD3 and CD20 in Canine Enteropathy-Associated T-cell Lymphoma.	PAX5
29372346	10.1007/s11894-018-0608-y	2018	Heavy Chain Disease of the Small Bowel.	PAX5
29380181	10.1007/s12185-018-2410-x	2018	Classical Hodgkin lymphoma type post-transplant lymphoproliferative disorder in a kidney transplant recipient: a diagnostic pitfall.	PAX5
29467311	10.1128/JVI.02155-17	2018	Epstein-Barr Virus Nuclear Antigen Leader Protein Coactivates EP300.	PAX5
29475930	10.21873/invivo.11255	2018	Primary Gastric EBV-positive Diffuse Large B Cell Lymphoma (DLBCL) of the Elderly with Plasmablastic Differentiation.	PAX5
29520434	10.1007/s00277-018-3291-z	2018	A patient with B-cell acute lymphoblastic leukemia with PAX5-ETV6 rearrangement with dic(9;12)(p13;p13) identified by chromosomal microarray.	PAX5
29572766	10.1007/s12185-018-2438-y	2018	CD3<sup>+</sup> CD56<sup>+</sup> EBER1<sup>+</sup> atypical extraosseous plasmacytoma of the nasal cavity.	PAX5
29575541	10.1111/ijlh.12805	2018	Simultaneous detection of ABL1 mutation and IKZF1 deletion in Philadelphia chromosome-positive acute lymphoblastic leukemia using a customized target enrichment system panel.	PAX5
29580085	10.1556/004.2018.007	2018	Monitoring minimal residual disease in canine lymphomas treated with modified L-COP or L-CHOP protocols.	PAX5
29598887	10.1016/j.prp.2018.03.001	2018	Expression of programmed cell death 1/programmed cell death ligand 1 in the tumor microenvironments of primary gastrointestinal diffuse large B cell lymphomas.	PAX5
29678441	10.1016/j.oooo.2018.01.010	2018	Acute lymphoblastic leukemia/lymphoma of the oral and maxillofacial region.	PAX5
29786757	10.1007/s12185-018-2474-7	2018	Copy number abnormality of acute lymphoblastic leukemia cell lines based on their genetic subtypes.	PAX5
29950528		2018	CD30, CD15, CD50, and PAX5 Expressions as Diagnostic Markers for Hodgkin Lymphoma (HL) and Systemic Anaplastic Large Cell Lymphoma (sALCL).	PAX5
30111389	10.7534/j.issn.1009-2137.2018.04.001	2018	[Study on Immunophenotypes and Gene of Acute Lymphoblastic Leukemia].	PAX5
30129396	10.1177/1040638718794765	2018	CD3 and CD20 co-expression in a case of canine peripheral T-cell lymphoma with prominent cardiac and peripheral nerve involvement.	PAX5
30203896	10.1002/gcc.22664	2018	Improved cytogenetic characterization and risk stratification of pediatric acute lymphoblastic leukemia using single nucleotide polymorphism array analysis: A single center experience of 296 cases.	PAX5
30257940	10.1073/pnas.1721678115	2018	PAX5-ELN oncoprotein promotes multistep B-cell acute lymphoblastic leukemia in mice.	PAX5
25665030	10.1111/vco.12137	2017	Liquid-based cytology and cell block immunocytochemistry in veterinary medicine: comparison with standard cytology for the evaluation of canine lymphoid samples.	PAX5
26067141	10.1097/PAI.0000000000000200	2017	Expression of TIA1 and PAX5 in Classical Hodgkin Lymphoma at Initial Diagnosis May Predict Clinical Outcome.	PAX5
26447896	10.1097/PAI.0000000000000236	2017	Distinguishing Classical Hodgkin Lymphoma, Gray Zone Lymphoma, and Large B-cell Lymphoma: A Proposed Scoring System.	PAX5
26549087	10.4103/0377-4929.168860	2017	Concomitant follicular lymphoma and histiocytic sarcoma: A rare progression, trans-differentiation or co-occurrence?	PAX5
26892479	10.3109/10428194.2016.1144881	2017	Clinical impact of ABL1 kinase domain mutations and IKZF1 deletion in adults under age 60 with Philadelphia chromosome-positive (Ph+) acute lymphoblastic leukemia (ALL): molecular analysis of CALGB (Alliance) 10001 and 9665.	PAX5
26957068	10.3760/cma.j.issn.0578-1310.2016.03.011	2017	[Copy number variations in pediatric ETV6/RUNX1 positive acute lymphoblastic leukemia].	PAX5
27016671	10.1016/j.molimm.2016.03.007	2017	PAX5 promotes pre-B cell proliferation by regulating the expression of pre-B cell receptor and its downstream signaling.	PAX5
27181063	10.1016/j.exphem.2016.04.011	2017	Comprehensive genomic analysis reveals FLT3 activation and a therapeutic strategy for a patient with relapsed adult B-lymphoblastic leukemia.	PAX5
27319306	10.1111/his.13017	2017	Oct2 and Bob1 are sensitive and specific markers in lineage determination of B cell lymphomas with no expression of conventional B cell markers.	PAX5
27341313	10.1111/bjh.14201	2017	The tumour microenvironment influences survival and time to transformation in follicular lymphoma in the rituximab era.	PAX5
27356711		2017	Application of Immunophenotyping and Heteroduplex Polymerase Chain Reaction (hPARR) for Diagnosis of Canine Lymphomas.	PAX5
27381906	10.1182/blood-2015-11-680843	2017	Long noncoding RNAs in B-cell development and activation.	PAX5
27431073	10.3760/cma.j.issn.0253-2727.2016.06.009	2017	[Expression of CD137 in tumor cells of Hodgkin lymphoma from Northern China and its application in pathological differential diagnosis].	PAX5
27498737	10.11406/rinketsu.57.900	2017	Familial acute lymphoblastic leukemia.	PAX5
27664237	10.1101/gad.283762.116	2017	Superenhancer reprogramming drives a B-cell-epithelial transition and high-risk leukemia.	PAX5
27684979	10.5858/arpa.2016-0232-RA	2017	Plasmablastic Lymphoma: A Review of Clinicopathologic Features and Differential Diagnosis.	PAX5
27740969	10.1097/PAS.0000000000000753	2017	ALK-positive Large B-cell Lymphoma: A Clinicopathologic Study of 26 Cases With Review of Additional 108 Cases in the Literature.	PAX5
27748274	10.4103/0971-5916.191747	2017	Level of PAX5 in differential diagnosis of non-Hodgkin's lymphoma.	PAX5
27870151	10.1002/gcc.22433	2017	Ph-like acute lymphoblastic leukemia with a novel PAX5-KIDINS220 fusion transcript.	PAX5
27888664	10.1002/dc.23638	2017	EBV-associated but HHV8-unrelated double-hit effusion-based lymphoma.	PAX5
27957801	10.1002/pbc.26363	2017	Genomic characterization of pediatric B-lymphoblastic lymphoma and B-lymphoblastic leukemia using formalin-fixed tissues.	PAX5
27979924	10.3324/haematol.2016.153023	2017	Tumor suppressors BTG1 and IKZF1 cooperate during mouse leukemia development and increase relapse risk in B-cell precursor acute lymphoblastic leukemia patients.	PAX5
27980301	10.3960/jslrt.56.119	2017	Six Cases of CD20-Positive Adult T-Cell Leukemia.	PAX5
28061782	10.1186/s13000-016-0593-0	2017	Double-hit lymphomas: clinical, morphological, immunohistochemical and cytogenetic study in a series of Brazilian patients with high-grade non-Hodgkin lymphoma.	PAX5
28069005	10.1186/s12917-016-0919-x	2017	Prognostic efficacy of the human B-cell lymphoma prognostic genes in predicting disease-free survival (DFS) in the canine counterpart.	PAX5
28191697	10.1111/pin.12515	2017	Composite lymphoma of peripheral T-cell lymphoma and Hodgkin lymphoma, mixed cellularity type; pathological and molecular analysis.	PAX5
28192788	10.1038/nature21076	2017	Metabolic gatekeeper function of B-lymphoid transcription factors.	PAX5
28193567	10.1016/j.leukres.2017.01.034	2017	Genomic analysis of adult B-ALL identifies potential markers of shorter survival.	PAX5
28202519	10.1158/0008-5472.CAN-16-2571	2017	Correlates of Prenatal and Early-Life Tobacco Smoke Exposure and Frequency of Common Gene Deletions in Childhood Acute Lymphoblastic Leukemia.	PAX5
28219927	10.15252/embj.201695495	2017	Molecular role of the PAX5-ETV6 oncoprotein in promoting B-cell acute lymphoblastic leukemia.	PAX5
28221211	10.1097/DAD.0000000000000700	2017	A Rare Case of CK20/CK7 Double Negative Merkel Cell Carcinoma.	PAX5
28296741	10.1097/MD.0000000000006311	2017	A cyclin D1-positive diffuse large B-cell lymphoma of germinal center B-cell-like subtype in the right tonsil: A rare case report.	PAX5
28369050	10.1038/ni.3716	2017	Antagonism of B cell enhancer networks by STAT5 drives leukemia and poor patient survival.	PAX5
28371317	10.1002/pbc.26539	2017	Molecular characterization of acute lymphoblastic leukemia with high CRLF2 gene expression in childhood.	PAX5
28401483	10.1007/s12032-017-0940-3	2017	Molecular profiling of gene copy number abnormalities in key regulatory genes in high-risk B-lineage acute lymphoblastic leukemia: frequency and their association with clinicopathological findings in Indian patients.	PAX5
28418282	10.5858/arpa.2016-0215-OA	2017	Immunohistochemical Detection of Hairy Cell Leukemia in Paraffin Sections: The Role of Pax5 and CD103 Double Staining to Improve Specificity and Sensitivity.	PAX5
28476192	10.1016/j.arcmed.2016.12.005	2017	Gene Expression Profiling of Acute Lymphoblastic Leukemia in Children with Very Early Relapse.	PAX5
28557976	10.1038/bjc.2017.152	2017	Mutations in TP53 and JAK2 are independent prognostic biomarkers in B-cell precursor acute lymphoblastic leukaemia.	PAX5
28591984	10.3760/cma.j.issn.0529-5807.2017.06.004	2017	[Clinicopathologic features and expression of OCT4 protein in testicular diffuse large B cell lymphoma].	PAX5
28655536	10.1016/j.exphem.2017.06.004	2017	B-cell identity as a metabolic barrier against malignant transformation.	PAX5
28783138	10.1038/labinvest.2017.73	2017	Flow cytometric sorting coupled with exon capture sequencing identifies somatic mutations in archival lymphoma tissues.	PAX5
25014106	10.1097/DAD.0000000000000127	2016	Specific skin infiltration as first sign of localized stage Hodgkin's lymphoma involving an epitrochlear node.	PAX5
25115512	10.3109/10428194.2014.953155	2016	PRDM1/BLIMP1: a tumor suppressor gene in B and T cell lymphomas.	PAX5
25553299	10.3343/alm.2015.35.1.152	2016	The first case report of composite bone marrow involvement by simultaneously developed peripheral T-cell lymphoma, not otherwise specified, and diffuse large B-cell lymphoma.	PAX5
25811675	10.3109/10428194.2015.1034706	2016	Two distinct molecular subtypes of chronic lymphocytic leukemia give new insights on the pathogenesis of the disease and identify novel therapeutic targets.	PAX5
25951811	10.1002/gcc.22251	2016	Identification of SPAG9 as a novel JAK2 fusion partner gene in pediatric acute lymphoblastic leukemia with t(9;17)(p24;q21).	PAX5
26073757	10.1038/leu.2015.140	2016	Differential PAX5 levels promote malignant B-cell infiltration, progression and drug resistance, and predict a poor prognosis in MCL patients independent of CCND1.	PAX5
26094714	10.1111/1348-0421.12272	2016	Paired box gene 5 isoforms A and B have different functions in transcriptional regulation of B cell development-related genes in immature B cells.	PAX5
26108914	10.1186/s13000-015-0315-z	2016	Clinicopathologic features of plasmablastic lymphoma: Single-center series of 8 cases from Saudi Arabia.	PAX5
26183638	10.1007/s12328-014-0462-x	2016	A case of primary pancreatic lymphoblastic lymphoma diagnosed by endoscopic ultrasound-guided fine-needle aspiration.	PAX5
26187868	10.1136/bcr-2015-211159	2016	PAX5-expressing ALK-negative anaplastic large cell lymphoma with extensive extranodal and nodal involvement.	PAX5
26193900	10.1136/jclinpath-2015-203145	2016	EBV-related primary splenic lymphocyte-depleted classical Hodgkin lymphoma.	PAX5
26214592	10.1038/ng.3362	2016	Genomics and drug profiling of fatal TCF3-HLF-positive acute lymphoblastic leukemia identifies recurrent mutation patterns and therapeutic options.	PAX5
26239088	10.1182/blood-2015-02-629600	2016	Expression of programmed cell death ligand 1 is associated with poor overall survival in patients with diffuse large B-cell lymphoma.	PAX5
26269126	10.1186/s12885-015-1586-1	2016	Somatic drivers of B-ALL in a model of ETV6-RUNX1; Pax5(+/-) leukemia.	PAX5
26286813	10.1007/s00428-015-1814-8	2016	Langerhans cell sarcoma following marginal zone lymphoma: expanding the knowledge on mature B cell plasticity.	PAX5
26310606	10.1111/bjh.13647	2016	Quantitative proteomic analysis reveals maturation as a mechanism underlying glucocorticoid resistance in B lineage ALL and re-sensitization by JNK inhibition.	PAX5
26311245	10.1128/CVI.00374-15	2016	Applied Protein and Molecular Techniques for Characterization of B Cell Neoplasms in Horses.	PAX5
26408659	10.1158/2159-8290.CD-15-0892	2016	Infection Exposure is a Causal Factor in B-cell Precursor Acute Lymphoblastic Leukemia as a Result of Pax5-Inherited Susceptibility.	PAX5
26426381	10.1097/PAS.0000000000000523	2016	NOTCH1, TP53, and MAP2K1 Mutations in Splenic Diffuse Red Pulp Small B-cell Lymphoma Are Associated With Progressive Disease.	PAX5
26456646	10.1016/j.bbrc.2015.10.011	2016	Histone acetyltransferase PCAF is involved in transactivation of Bcl-6 and Pax5 genes in immature B cells.	PAX5
26458662	10.4103/0973-1482.140792	2016	CD20 negative primary diffuse large B cell lymphoma of breast: Role of Pax-5.	PAX5
26464729		2016	Composite primary breast diffuse large B-cell lymphoma and T lymphoblastic leukemia/lymphoma: report of a case and review of literature.	PAX5
26487345	10.1038/srep15215	2016	Transcription factor and miRNA co-regulatory network reveals shared and specific regulators in the development of B cell and T cell.	PAX5
26494837	10.3324/haematol.2015.132332	2016	PAX5-ESRRB is a recurrent fusion gene in B-cell precursor pediatric acute lymphoblastic leukemia.	PAX5
26520622	10.1016/j.leukres.2015.10.006	2016	Preserved global histone H4 acetylation linked to ETV6-RUNX1 fusion and PAX5 deletions is associated with favorable outcome in pediatric B-cell progenitor acute lymphoblastic leukemia.	PAX5
26526666	10.1007/s00431-015-2660-z	2016	Hodgkin lymphoma as a novel presentation of familial DICER1 syndrome.	PAX5
26574847	10.1097/PAS.0000000000000571	2016	CD30 Expression by B and T Cells: A Frequent Finding in Angioimmunoblastic T-Cell Lymphoma and Peripheral T-Cell Lymphoma-Not Otherwise Specified.	PAX5
26626503	10.1016/j.ejmg.2015.11.009	2016	GEMMs addressing Pax5 loss-of-function in childhood pB-ALL.	PAX5
26703467	10.1074/jbc.M115.637835	2016	B Cell Linker Protein (BLNK) Is a Selective Target of Repression by PAX5-PML Protein in the Differentiation Block That Leads to the Development of Acute Lymphoblastic Leukemia.	PAX5
26715530	10.1186/s13000-015-0450-6	2016	Discordant lymphoma consisting of mediastinal large B-cell lymphoma and nodular sclerosis Hodgkin lymphoma in the right supraclavicular lymph nodes: a case report.	PAX5
26762526	10.1007/s00428-015-1902-9	2016	Intrafollicular Epstein-Barr virus-positive large B cell lymphoma. A variant of germinotropic lymphoproliferative disorder.	PAX5
26781410		2016	[Detection of copy number variations in pediatric ETV6/RUNX1-positive acute lymphoblastic leukemia with multiplex ligation-dependent probe amplification].	PAX5
26785729	10.1074/mcp.M115.054593	2016	High-resolution Antibody Array Analysis of Childhood Acute Leukemia Cells.	PAX5
26791260	10.1186/s13000-016-0464-8	2016	Primary diffuse large B cell lymphoma arising from a leiomyoma of the uterine corpus.	PAX5
26819314	10.1128/JVI.03227-15	2016	Induction of Epstein-Barr Virus Oncoprotein LMP1 by Transcription Factors AP-2 and Early B Cell Factor.	PAX5
27097569		2016	[Significance of PAX5 deletion in childhood B-lineage acute lymphoblastic leukemia without reproducible chromosomal abnormalities].	PAX5
27656544	10.7860/JCDR/2016/21476.8352	2016	Diagnostic Utility of PAX5 in Hodgkin and Non-Hodgkin Lymphoma: A Study from Northern India.	PAX5
24406862	10.1038/modpathol.2013.250	2015	Merkel cell carcinoma of lymph node with unknown primary has a significantly lower association with Merkel cell polyomavirus than its cutaneous counterpart.	PAX5
24467775	10.1111/cup.12299	2015	Mycosis fungoides with CD20 expression: report of two cases and review of the literature.	PAX5
24633193	10.1038/modpathol.2014.44	2015	A novel immunohistochemical classifier to distinguish Hodgkin lymphoma from ALK anaplastic large cell lymphoma.	PAX5
24731193	10.1111/vcp.12138	2015	Application of the tissue transfer technique in veterinary cytopathology.	PAX5
24852241	10.1016/j.anndiagpath.2014.03.007	2015	Epstein-Barr virus-positive nodular lymphocyte predominant Hodgkin lymphoma.	PAX5
24921642	10.1097/PAS.0000000000000266	2015	Variable expression of B-cell transcription factors in reactive immunoblastic proliferations: a potential mimic of classical Hodgkin lymphoma.	PAX5
24957142	10.1182/blood-2014-03-562918	2015	A novel integrated cytogenetic and genomic classification refines risk stratification in pediatric acute lymphoblastic leukemia.	PAX5
25030862		2015	[Grey zone lymphoma with features intermediate between diffuse large B-cell lymphoma and classical Hodgkin lymphoma: clinicopathologic characterization of 16 cases showing different patterns].	PAX5
25040178	10.1111/exd.12490	2015	Merkel cell carcinoma: is this a true carcinoma?	PAX5
25043849	10.1002/gcc.22204	2015	Deregulated FOX genes in Hodgkin lymphoma.	PAX5
25044358	10.1002/gcc.22201	2015	Gene alterations involving the CRLF2-JAK pathway and recurrent gene deletions in Down syndrome-associated acute lymphoblastic leukemia in Japan.	PAX5
25099172	10.1111/cup.12379	2015	Primary cutaneous follicle center lymphoma with Hodgkin and Reed-Sternberg-like cells: a new histopathologic variant.	PAX5
25261097	10.3324/haematol.2014.112912	2015	Novel gene targets detected by genomic profiling in a consecutive series of 126 adults with acute lymphoblastic leukemia.	PAX5
25273521	10.1186/s13000-014-0188-6	2015	Diagnosis of primary pulmonary T- cell/histiocyte-rich large B cell lymphoma with tissue eosinophilia via clinicopathological observation and molecular assay.	PAX5
25283946	10.1292/jvms.14-0088	2015	A rare case of hepatic T-cell rich B-cell lymphoma (TCRBCL) in a juvenile dog.	PAX5
25304615	10.3324/haematol.2014.112193	2015	Three novel fusion transcripts of the paired box 5 gene in B-cell precursor acute lymphoblastic leukemia.	PAX5
25318949	10.3960/jslrt.54.155	2015	CD5- and CD23-positive splenic diffuse large B-cell lymphoma with very low CD20 expression.	PAX5
25338558	10.7534/j.issn.1009-2137.2014.05.003	2015	[Mutation and expression of PAX5 gene in adult acute lymphoblastic leukemia].	PAX5
25394195	10.1111/pin.12221	2015	Intrafollicular classical Hodgkin lymphoma mimicking nodular lymphocyte predominant Hodgkin lymphoma: a report of two cases.	PAX5
25439346	10.1016/j.humpath.2014.09.002	2015	Diffuse large B-cell lymphoma occurring in an ovarian cystic teratoma: expanding the spectrum of large B-cell lymphoma associated with chronic inflammation.	PAX5
25515960	10.1182/blood-2014-04-570960	2015	The role of the Janus-faced transcription factor PAX5-JAK2 in acute lymphoblastic leukemia.	PAX5
25573326	10.1007/s11010-014-2325-7	2015	Spleen-specific isoforms of Pax5 and Ataxin-7 as potential proteomic markers of lymphoma-affected spleen.	PAX5
25595912	10.18632/oncotarget.2807	2015	LCK over-expression drives STAT5 oncogenic signaling in PAX5 translocated BCP-ALL patients.	PAX5
25631385	10.1038/srep08117	2015	PhenomeExpress: a refined network analysis of expression datasets by inclusion of known disease phenotypes.	PAX5
25634193	10.1097/MD.0000000000000470	2015	Plasmablastic lymphoma of the stomach with C-MYC rearrangement in an immunocompetent young adult: a case report.	PAX5
25656449	10.1016/j.cellimm.2015.01.010	2015	BRAD4 plays a critical role in germinal center response by regulating Bcl-6 and NF-κB activation.	PAX5
25706938	10.1002/gcc.22246	2015	A population-based single nucleotide polymorphism array analysis of genomic aberrations in younger adult acute lymphoblastic leukemia patients.	PAX5
25745968	10.11406/rinketsu.56.41	2015	[Primary pulmonary Hodgkin lymphoma diagnosed by CT-guided percutaneous biopsy].	PAX5
25748621	10.5604/17322693.1142719	2015	Genes and childhood leukemia.	PAX5
25855603	10.1182/blood-2015-02-626127	2015	PAX5 is a tumor suppressor in mouse mutagenesis models of acute lymphoblastic leukemia.	PAX5
25970684	10.1097/PAS.0000000000000396	2015	Loss of B-cell receptor expression defines a subset of diffuse large B-cell lymphoma characterized by silent BCR/PI3K/AKT signaling and a germinal center phenotype displaying low-risk clinicopathologic features.	PAX5
25990863	10.1182/blood-2014-12-575688	2015	Transcription factor networks in B-cell differentiation link development to acute lymphoid leukemia.	PAX5
26301807	10.1172/JCI83799	2015	A robust in vivo model for B cell precursor acute lymphoblastic leukemia.	PAX5
26301816	10.1172/JCI81158	2015	Comparative genomics reveals multistep pathogenesis of E2A-PBX1 acute lymphoblastic leukemia.	PAX5
26380128	10.1155/2015/651764	2015	B Cell Lymphoma, Unclassifiable, Transformed from Follicular Lymphoma: A Rare Presentation with Review of the Literature.	PAX5
21900543	10.1177/0300985811419531	2014	Neurolymphomatosis in a dog with B-cell lymphoma.	PAX5
22346751	10.1371/journal.ppat.1002516	2014	The B-cell specific transcription factor, Oct-2, promotes Epstein-Barr virus latency by inhibiting the viral immediate-early protein, BZLF1.	PAX5
23007953	10.1002/dc.22918	2014	De novo CD5-positive primary cardiac diffuse large B-cell lymphoma diagnosed by pleural fluid cytology.	PAX5
23190578	10.1111/ijlh.12031	2014	Interphase-FISH screening for eight common rearrangements in pediatric B-cell precursor acute lymphoblastic leukemia.	PAX5
23508010	10.3324/haematol.2013.085175	2014	Genes commonly deleted in childhood B-cell precursor acute lymphoblastic leukemia: association with cytogenetics and clinical features.	PAX5
23512149	10.1007/s00795-013-0038-8	2014	B-cell lymphoma, unclassifiable, with features intermediate between diffuse large B-cell lymphoma and classical Hodgkin lymphoma without mediastinal disease: mimicking nodular sclerosis classical Hodgkin lymphoma.	PAX5
23544448	10.5732/cjc.012.10221	2014	A Chinese patient with relapsed and refractory Hodgkin lymphoma treated with brentuximab vedotin.	PAX5
23599149	10.1038/modpathol.2013.73	2014	ALK-positive large B-cell lymphomas express a terminal B-cell differentiation program and activated STAT3 but lack MYC rearrangements.	PAX5
23733446	10.1007/s12185-013-1358-0	2014	Discordant lymphocyte-depleted classical Hodgkin's and peripheral T-cell lymphoma arising in a patient 11 years after diagnosis of multicentric Castleman's disease.	PAX5
23737402	10.1002/hon.2079	2014	PAX5 somatic mutation is rare in multiple myelomas and non-Hodgkin lymphomas of Korean patients.	PAX5
23775019	10.1177/1066896913491318	2014	A rare case of anaplastic variant of diffuse large B-cell lymphoma presenting as a lung primary.	PAX5
23794479	10.1136/jclinpath-2013-201707	2014	An unusual case of biphenotypic, bigenotypic mature lymphoma.	PAX5
23826425		2014	Uterine leiomyoma with indolent B-lymphoblastic proliferation.	PAX5
23842424	10.1038/leu.2013.211	2014	PAX5 overexpression is not enough to reestablish the mature B-cell phenotype in classical Hodgkin lymphoma.	PAX5
24029709	10.1016/j.humpath.2013.06.006	2014	B cells in classical Hodgkin lymphoma are important actors rather than bystanders in the local immune reaction.	PAX5
24168387	10.1111/petr.12180	2014	Very late relapse of PTLD 10 yr after allogeneic HSCT and nine yr after stopping immunosuppressive therapy.	PAX5
24240734	10.1007/s00401-013-1202-x	2014	Systems biology of primary CNS lymphoma: from genetic aberrations to modeling in mice.	PAX5
24240978	10.1007/s00277-013-1959-y	2014	A rare IgM multiple myeloma with aberrant PAX5 expression mimicking lymphoplasmacytic lymphoma.	PAX5
24247573	10.1097/DAD.0b013e31827b9450	2014	CD20+ mycosis fungoides: a report of three cases and review of the literature.	PAX5
24270736	10.1038/leu.2013.354	2014	CD2-positive B-cell precursor acute lymphoblastic leukemia with an early switch to the monocytic lineage.	PAX5
24287434	10.1038/leu.2013.363	2014	Inherited susceptibility to pre B-ALL caused by germline transmission of PAX5 c.547G&gt;A.	PAX5
24344258	10.1073/pnas.1321704111	2014	Epstein-Barr virus nuclear antigen 3C binds to BATF/IRF4 or SPI1/IRF4 composite sites and recruits Sin3A to repress CDKN2A.	PAX5
24369229	10.3960/jslrt.53.251	2014	Refractory case of ALK-negative anaplastic large-cell lymphoma with PAX-5 expression and T-cell receptor-γ gene rearrangement.	PAX5
24427370		2014	Primary thyroid T-lymphoblastic lymphoma: a case report and review of the literature.	PAX5
24433739		2014	[B/T-cell biphenotypic lymphoblastic lymphoma/leukemia: report of a case].	PAX5
24507104		2014	[CD5-positive cardiac intravascular diffuse large-B cell lymphoma: report of a case].	PAX5
24525501	10.1097/PAS.0000000000000107	2014	EBV may be expressed in the LP cells of nodular lymphocyte-predominant Hodgkin lymphoma (NLPHL) in both children and adults.	PAX5
24569775	10.1038/leu.2014.87	2014	The role of PAX5 and C/EBP α/β in atypical non-Langerhans cell histiocytic tumor post acute lymphoblastic leukemia.	PAX5
24602166	10.1186/1471-2407-14-159	2014	Increased paired box transcription factor 8 has a survival function in glioma.	PAX5
24685599	10.1159/000360359	2014	Extraoral plasmablastic lymphoma detected using ascitic fluid cytology and flow cytometry: a case report with a review of the literature.	PAX5
24735925	10.1016/j.ccr.2014.03.008	2014	Proteasome inhibitors evoke latent tumor suppression programs in pro-B MLL leukemias through MLL-AF4.	PAX5
24753091	10.1002/ajh.23727	2014	Genomic ancestry and somatic alterations correlate with age at diagnosis in Hispanic children with B-cell acute lymphoblastic leukemia.	PAX5
24939936	10.1101/gad.240416.114	2014	Pax5 loss imposes a reversible differentiation block in B-progenitor acute lymphoblastic leukemia.	PAX5
25143841	10.1155/2014/874725	2014	Aggressive Subcutaneous Panniculitis-Like CD30+ Peripheral T-Cell Lymphoma with Diffuse EBER Expression.	PAX5
25364541	10.3978/j.issn.2072-1439.2014.08.45	2014	Primary intravascular large B-cell lymphoma of the lung: a review and case report.	PAX5
25478252	10.1155/2014/145129	2014	A rare presentation of in situ mantle cell lymphoma and follicular lymphoma: a case report and review of the literature.	PAX5
21854813	10.1016/j.bbamcr.2011.08.003	2013	Isoforms of Pax5 and co-regulation of T- and B-cells associated genes influence phenotypic traits of ascetic cells causing Dalton's lymphoma.	PAX5
22683202	10.1016/j.anndiagpath.2012.05.004	2013	Chronic lymphocytic leukemia/small lymphocytic lymphoma involving the aortic valve.	PAX5
22699455	10.1038/leu.2012.155	2013	Prognostic value of genetic alterations in children with first bone marrow relapse of childhood B-cell precursor acute lymphoblastic leukemia.	PAX5
22789917	10.1016/j.critrevonc.2012.06.004	2013	Anaplastic large cell lymphoma, ALK-negative.	PAX5
22800529	10.3760/cma.j.issn.0529-5807.2012.04.016	2013	[Neoplastic counterpart of interfollicular dendritic large B cells: report of a case].	PAX5
22927250	10.1182/blood-2012-03-414821	2013	Biphenotypic B-lymphoid/myeloid cells expressing low levels of Pax5: potential targets of BAL development.	PAX5
22932404	10.3760/cma.j.issn.0529-5807.2012.06.004	2013	[Clinicopathologic study of 40 cases of mediastinal tumours of haematopoietic and lymphoid tissues].	PAX5
23020783	10.3109/10428194.2012.733881	2013	Clinicopathological analysis of mediastinal large B-cell lymphoma and classical Hodgkin lymphoma of the mediastinum.	PAX5
23066952	10.3109/10428194.2012.739687	2013	Mutation mismatch repair gene deletions in diffuse large B-cell lymphoma.	PAX5
23118213	10.1182/blood-2012-09-455113	2013	Transcription factor dose links development to disease.	PAX5
23121609	10.1111/pin.12005	2013	Plasmablastic lymphoma of the stomach in an HIV-negative patient.	PAX5
23163626	10.1111/his.12020	2013	PAX8 and PAX5 are differentially expressed in B-cell and T-cell lymphomas.	PAX5
23167388	10.7314/apjcp.2012.13.9.4607	2013	Weighted gene co-expression network analysis in identification of endometrial cancer prognosis markers.	PAX5
23171357	10.1111/j.1365-2559.2012.04351.x	2013	Does the proliferation fraction help identify mature B cell lymphomas with double- and triple-hit translocations?	PAX5
23174882	10.1038/leu.2012.280	2013	Role of early B-cell factor 1 (EBF1) in Hodgkin lymphoma.	PAX5
23255160	10.1007/s12185-012-1244-1	2013	Clinicopathologic spectrum and EBV status of post-transplant lymphoproliferative disorders after allogeneic hematopoietic stem cell transplantation.	PAX5
23282972	10.1097/PAS.0b013e31826cb1d1	2013	Plasmablastic transformation of low-grade B-cell lymphomas: report on 6 cases.	PAX5
23302315	10.3760/cma.j.issn.0529-5807.2012.10.013	2013	[Clear cell renal carcinoma coexisting with primary renal lymphoma: report of a case].	PAX5
23321250	10.1182/blood-2012-06-438937	2013	SOX11 regulates PAX5 expression and blocks terminal B-cell differentiation in aggressive mantle cell lymphoma.	PAX5
23329999		2013	Immunohistochemical expression of PAX5 and TdT by Merkel cell carcinoma and pulmonary small cell carcinoma: a potential diagnostic pitfall but useful discriminatory marker.	PAX5
23336228	10.3760/cma.j.issn.0253-2727.2012.09.011	2013	[Clinicopathologic and cytogenetic features of 114 Chinese mantle cell lymphoma cases].	PAX5
23355206	10.1309/AJCP0YGM8BLFYHJY	2013	Nuclear protein dysregulation in lymphoplasmacytic lymphoma/waldenstrom macroglobulinemia.	PAX5
23425357	10.1186/1746-1596-8-30	2013	Primary submucosal nodular plasmacytoma of the stomach: a poorly recognized variant of gastric lymphoma.	PAX5
23443779		2013	[CD99 regulates redifferentiation of classical Hodgkin's lymphoma cell line L428 towards B cells].	PAX5
23520328	10.1182/blood-2013-02-480418	2013	SOX11 is a mantle cell lymphoma oncogene.	PAX5
23529845	10.1007/s12185-013-1309-9	2013	PAX5 alteration-associated gene-expression signatures in B-cell acute lymphoblastic leukemia.	PAX5
23538749	10.1038/leu.2013.92	2013	Impact of IKZF1 deletions and PAX5 amplifications in pediatric B-cell precursor ALL treated according to NOPHO protocols.	PAX5
23569445	10.1159/000346838	2013	Extracavitary manifestation of primary effusion lymphoma as a right atrial mass.	PAX5
23598959	10.1097/PAS.0b013e3182785610	2013	Peripheral T-cell lymphomas of follicular T-helper cell derivation with Hodgkin/Reed-Sternberg cells of B-cell lineage: both EBV-positive and EBV-negative variants exist.	PAX5
23678172	10.1128/JVI.00546-13	2013	The B-cell-specific transcription factor and master regulator Pax5 promotes Epstein-Barr virus latency by negatively regulating the viral immediate early protein BZLF1.	PAX5
23738160	10.1155/2013/386147	2013	A Unique Composite PTLD with Diffuse Large B-Cell and T/Anaplastic Large Cell Lymphoma Components Occurring 17 Years after Transplant.	PAX5
23845468	10.1016/j.humpath.2013.04.011	2013	IMP3 as a supplemental diagnostic marker for Hodgkin lymphoma.	PAX5
23852341	10.1038/nm.3247	2013	BACH2 mediates negative selection and p53-dependent tumor suppression at the pre-B cell receptor checkpoint.	PAX5
23928529	10.3760/cma.j.issn.0529-5807.2013.04.005	2013	[Clinicopathologic features and differential diagnosis of splenic B-cell marginal zone lymphoma involving bone marrow].	PAX5
24013638	10.1038/ng.2754	2013	A recurrent germline PAX5 mutation confers susceptibility to pre-B cell acute lymphoblastic leukemia.	PAX5
24071841	10.1038/ng.2778	2013	Germline PAX5 mutations and B cell leukemia.	PAX5
24081948	10.1084/jem.20130497	2013	Aberrant ZNF423 impedes B cell differentiation and is linked to adverse outcome of ETV6-RUNX1 negative B precursor acute lymphoblastic leukemia.	PAX5
24145652	10.1097/PAS.0000000000000091	2013	CD20 antigen may be expressed by reactive or lymphomatous cells of transformed mycosis fungoides: diagnostic and prognostic impact.	PAX5
20435627	10.3324/haematol.2009.011114	2012	Genomic profiling of adult acute lymphoblastic leukemia by single nucleotide polymorphism oligonucleotide microarray and comparison to pediatric acute lymphoblastic leukemia.	PAX5
21666687	10.1038/modpathol.2011.102	2012	Clonally related histiocytic/dendritic cell sarcoma and chronic lymphocytic leukemia/small lymphocytic lymphoma: a study of seven cases.	PAX5
21765475	10.1038/onc.2011.291	2012	Dominant-negative mechanism of leukemogenic PAX5 fusions.	PAX5
21813177	10.1016/j.leukres.2011.07.017	2012	Evaluation of PAX5 gene in the early stages of leukemic B cells in the childhood B cell acute lymphoblastic leukemia.	PAX5
21813545	10.1177/1066896911417242	2012	Concurrent gastric MALT and Hodgkin lymphoma: a case report.	PAX5
21835430	10.1016/j.humpath.2011.02.029	2012	Folliculocentric B-cell-rich follicular dendritic cells sarcoma: a hitherto unreported morphological variant mimicking lymphoproliferative disorders.	PAX5
21859738	10.3324/haematol.2011.041079	2012	Cytotoxic molecule-positive classical Hodgkin's lymphoma: a clinicopathological comparison with cytotoxic molecule-positive peripheral T-cell lymphoma of not otherwise specified type.	PAX5
21882283	10.1002/gcc.20919	2012	Microarray-based genomic profiling as a diagnostic tool in acute lymphoblastic leukemia.	PAX5
22020966	10.1002/ijc.26503	2012	CD99 triggers upregulation of miR-9-modulated PRDM1/BLIMP1 in Hodgkin/Reed-Sternberg cells and induces redifferentiation.	PAX5
22037256	10.1038/modpathol.2011.162	2012	N-terminal PAX8 polyclonal antibody shows cross-reactivity with N-terminal region of PAX5 and is responsible for reports of PAX8 positivity in malignant lymphomas.	PAX5
22072402	10.1002/gcc.20944	2012	High frequency of BTG1 deletions in acute lymphoblastic leukemia in children with down syndrome.	PAX5
22127311	10.1016/j.beha.2011.09.004	2012	Genomic profiling of B-progenitor acute lymphoblastic leukemia.	PAX5
22127921	10.1158/0008-5472.CAN-11-1874	2012	The Pax-5 gene: a pluripotent regulator of B-cell differentiation and cancer disease.	PAX5
22184374	10.1200/JCO.2011.38.8553	2012	Histiocytic sarcoma arising from clonally related mantle cell lymphoma.	PAX5
22241086	10.1158/0008-5472.CAN-11-1659	2012	B effector cells activated by a chimeric protein consisting of IL-2 and the ectodomain of TGF-β receptor II induce potent antitumor immunity.	PAX5
22259636	10.5045/kjh.2011.46.4.283	2012	Primary cutaneous B-cell lymphoblastic lymphoma in an elderly man.	PAX5
22324490	10.1111/j.1600-0560.2012.01872.x	2012	Use of an expanded immunohistochemical panel to distinguish cutaneous Hodgkin lymphoma from histopathologic imitators.	PAX5
22357631	10.4049/jimmunol.1101111	2012	2,3,7,8-tetrachlorodibenzo-p-dioxin induces transcriptional activity of the human polymorphic hs1,2 enhancer of the 3'Igh regulatory region.	PAX5
22367293	10.1097/PAS.0b013e3182487158	2012	Nodal involvement by cutaneous CD30-positive T-cell lymphoma mimicking classical Hodgkin lymphoma.	PAX5
22373549	10.1007/s00277-012-1431-4	2012	Detection of ETV6 gene rearrangements in adult acute lymphoblastic leukemia.	PAX5
22441210	10.1038/leu.2012.84	2012	Outcome in children with Down's syndrome and acute lymphoblastic leukemia: role of IKZF1 deletions and CRLF2 aberrations.	PAX5
22449230	10.1111/j.1440-1827.2011.02784.x	2012	Primary cutaneous CD30 positive T-cell lymphoproliferative disorders with aberrant expression of PAX5: report of three cases.	PAX5
22486304	10.1089/vim.2011.0073	2012	Interleukin-21 inhibits humoral response to an HIV DNA vaccine by enhancing Bcl-6 and Pax-5 expression.	PAX5
22531924	10.1002/eji.201141442	2012	Modulation of PKC-α promotes lineage reprogramming of committed B lymphocytes.	PAX5
22546857	10.1172/JCI45851	2012	CD19 is a major B cell receptor-independent activator of MYC-driven B-lymphomagenesis.	PAX5
22572037	10.1016/j.prp.2012.04.003	2012	A malignant lymphoma with histological features and immunophenotypic profile intermediate between EBV-positive diffuse large B-cell lymphoma and EBV-positive classical Hodgkin lymphoma in a 67-year-old female: a gray zone lymphoma associated with Epstein-Barr virus in the elderly.	PAX5
22578776	10.1016/j.leukres.2012.04.015	2012	PAX5-AUTS2: a recurrent fusion gene in childhood B-cell precursor acute lymphoblastic leukemia.	PAX5
22593617	10.4049/jimmunol.1103039	2012	B cell receptor-ERK1/2 signal cancels PAX5-dependent repression of BLIMP1 through PAX5 phosphorylation: a mechanism of antigen-triggering plasma cell differentiation.	PAX5
22851563	10.1200/JCO.2011.40.3907	2012	IGH@ translocations, CRLF2 deregulation, and microdeletions in adolescents and adults with acute lymphoblastic leukemia.	PAX5
20534699	10.3324/haematol.2009.020792	2011	The PAX5 gene is frequently rearranged in BCR-ABL1-positive acute lymphoblastic leukemia but is not associated with outcome. A report on behalf of the GIMEMA Acute Leukemia Working Party.	PAX5
20972455	10.1038/onc.2010.473	2011	The reduced and altered activities of PAX5 are linked to the protein-protein interaction motif (coiled-coil domain) of the PAX5-PML fusion protein in t(9;15)-associated acute lymphocytic leukemia.	PAX5
21156323	10.1016/j.leukres.2010.11.015	2011	Epigenetic regulation of PAX5 expression in acute T-cell lymphoblastic leukemia.	PAX5
21299464	10.3109/10428194.2011.553001	2011	Paired box gene 5 may modulate Proviral Integration of Moloney virus 2 gene and protein expression in mature B-cells.	PAX5
21424034		2011	B-cell transcription factors Pax-5, Oct-2, BOB.1, Bcl-6, and MUM1 are useful markers for the diagnosis of nodular lymphocyte predominant Hodgkin lymphoma.	PAX5
21480862	10.1111/j.1365-2141.2011.08677.x	2011	Expression of PAX5 splice variants: a phenomenon of stress-induced, illegitimate splicing?	PAX5
21490448	10.1097/PAS.0b013e3182147f91	2011	Coexisting and clonally identical classic hodgkin lymphoma and nodular lymphocyte predominant hodgkin lymphoma.	PAX5
21527530	10.1182/blood-2011-01-329961	2011	Genomic characterization implicates iAMP21 as a likely primary genetic event in childhood B-cell precursor acute lymphoblastic leukemia.	PAX5
21549623	10.1016/j.bcmd.2011.04.003	2011	PAX5 deletion is common and concurrently occurs with CDKN2A deletion in B-lineage acute lymphoblastic leukemia.	PAX5
21606506	10.1084/jem.20101947	2011	Ebf1 or Pax5 haploinsufficiency synergizes with STAT5 activation to initiate acute lymphoblastic leukemia.	PAX5
21638769	10.1002/cyto.b.20598	2011	Case Study Interpretation--Houston: Case 2. Classical Hodgkin lymphoma.	PAX5
21722099	10.1111/j.1365-2141.2011.08760.x	2011	Immunohistochemical distinction of haematogones from B lymphoblastic leukaemia/lymphoma or B-cell acute lymphoblastic leukaemia (B-ALL) on bone marrow trephine biopsies: a study on 62 patients.	PAX5
21962897	10.1016/j.cancergen.2011.07.006	2011	FOXP1 and PAX5 are rare but recurrent translocations partners in acute lymphoblastic leukemia.	PAX5
21990402	10.1200/JCO.2011.36.9280	2011	Peripheral T-cell lymphoma with aberrant expression of CD30, CD15, and CD20.	PAX5
18718064		2010	[Effect of pax5 gene blocked by RNAi on biological characteristics of B cell malignant lymphoma].	PAX5
19725825	10.1111/j.1365-2141.2009.07859.x	2010	Multiple isoforms of PAX5 are expressed in both lymphomas and normal B-cells.	PAX5
20023257	10.1309/AJCPYP00JNUFWCCY	2010	Expression profiling of transcription factors in B- or T-acute lymphoblastic leukemia/lymphoma and burkitt lymphoma: usefulness of PAX5 immunostaining as pan-Pre-B-cell marker.	PAX5
20118907	10.1038/modpathol.2010.4	2010	PAX5-positive T-cell anaplastic large cell lymphomas associated with extra copies of the PAX5 gene locus.	PAX5
20160164	10.1182/blood-2009-07-234229	2010	Wide diversity of PAX5 alterations in B-ALL: a Groupe Francophone de Cytogenetique Hematologique study.	PAX5
20233627	10.1016/j.leukres.2010.02.017	2010	Mismatch repair and the downstream target genes, PAX5 and Ikaros, in childhood acute lymphoblastic leukemia.	PAX5
18643853	10.1111/j.1365-2559.2008.03091.x	2009	PAX-5 is invariably expressed in B-cell lymphomas without plasma cell differentiation.	PAX5
19020546	10.1038/leu.2008.306	2009	Incidence and diversity of PAX5 fusion genes in childhood acute lymphoblastic leukemia.	PAX5
19145202	10.1097/PAS.0b013e318191614f	2009	PAX immunoreactivity identifies alveolar rhabdomyosarcoma.	PAX5
19368954	10.1016/j.humpath.2009.01.007	2009	Rare lymphoid neoplasms coexpressing B- and T-cell antigens. The role of PAX-5 gene methylation in their pathogenesis.	PAX5
19586940	10.3324/haematol.2008.002808	2009	Heterogeneous breakpoints in patients with acute lymphoblastic leukemia and the dic(9;20)(p11-13;q11) show recurrent involvement of genes at 20q11.21.	PAX5
19587702	10.1038/leu.2009.135	2009	PAX5 mutations occur frequently in adult B-cell progenitor acute lymphoblastic leukemia and PAX5 haploinsufficiency is associated with BCR-ABL1 and TCF3-PBX1 fusion genes: a GRAALL study.	PAX5
18957548	10.1073/pnas.0803494105	2008	Variable breakpoints target PAX5 in patients with dicentric chromosomes: a model for the basis of unbalanced translocations in cancer.	PAX5
17344859	10.1038/nature05690	2007	Genome-wide analysis of genetic alterations in acute lymphoblastic leukaemia.	PAX5
17431414	10.1038/modpathol.3800778	2007	Rare expression of BSAP (PAX-5) in mature T-cell lymphomas.	PAX5
17476282	10.1038/sj.leu.2404706	2007	Analysis of BCL-6, CD95, PIM1, RHO/TTF and PAX5 mutations in splenic and nodal marginal zone B-cell lymphomas suggests a particular B-cell origin.	PAX5
17529924	10.1038/modpathol.3800831	2007	The utility of PAX5 immunohistochemistry in the diagnosis of undifferentiated malignant neoplasms.	PAX5
17535098	10.2350/06-04-0082.1	2007	Anaplastic large cell lymphomas: a study of 75 pediatric patients.	PAX5
17635241	10.1111/j.1600-0609.2007.00882.x	2007	Biphenotypic bigenotypic lymphoma with simultaneous expression of PAX5/BSAP and B- and T-cell markers.	PAX5
17717600	10.1172/JCI30842	2007	B cell activator PAX5 promotes lymphomagenesis through stimulation of B cell receptor signaling.	PAX5
16541139	10.1038/sj.leu.2404183	2006	Richter's and prolymphocytic transformation of chronic lymphocytic leukemia are associated with high mRNA expression of activation-induced cytidine deaminase and aberrant somatic hypermutation.	PAX5
17050077	10.1309/XEC7-JMW9-YRM7-4RNO	2006	Pax-5 expression in nonhematopoietic tissues.	PAX5
15385562	10.1074/jbc.M407171200	2005	Human Pax-5 C-terminal isoforms possess distinct transactivation properties and are differentially modulated in normal and malignant B cells.	PAX5
15492262	10.1158/0008-5472.CAN-04-1865	2004	PAX5 expression in acute leukemias: higher B-lineage specificity than CD79a and selective association with t(8;21)-acute myelogenous leukemia.	PAX5
12609061		2003	[Expression and significance of B-cell-specific activator protein of H/RS cell in classical Hodgkin's Lymphoma].	PAX5
11460166	10.1038/35085588	2001	Hypermutation of multiple proto-oncogenes in B-cell diffuse large-cell lymphomas.	PAX5
10197586		1999	The partial homeodomain of the transcription factor Pax-5 (BSAP) is an interaction motif for the retinoblastoma and TATA-binding proteins.	PAX5
8650231	10.1073/pnas.93.12.6129	1996	Deregulation of PAX-5 by translocation of the Emu enhancer of the IgH locus adjacent to two alternative PAX-5 promoters in a diffuse large-cell lymphoma.	PAX5
8943844		1996	The t(9;14)(p13;q32) chromosomal translocation associated with lymphoplasmacytoid lymphoma involves the PAX-5 gene.	PAX5
